HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement CVD Claims Fill US FDA Warning Radar

Executive Summary

Day after warning consumers about yet another supplement containing undisclosed ED drug ingredients, FDA announces its found supplements claiming to prevent or treat CVD, or related conditions such as atherosclerosis, stroke, or heart failure.

You may also be interested in...



US Omega-3 Supplement Firm Changes Claims On Amarin Challenge, But Not Label Or Company Name

National Advertising Division, in rare review of an Rx drug firm’s challenge of supplement ad claims, reported Innovix Pharma pulled health claims for OmegaVia brand supplements challenged by Amarin. Innovix prevailed in defending its labeling as accurate and its name as not false advertising.

Health, Beauty And Wellness Regulatory News: FDA, Kratom Group Trade Criticisms, LifeLink 'Key Words' Warned

FDA's latest concern about kratom is "disturbingly high levels of heavy metals," but American Kratom Association adds to its reasons for "strong objections to methodology and lack of scientific rigor" in agency's finding that kratom is unsafe because some constituent ingredients are opioids. LifeLink supplement marketer caught FDA's attention not only for drug claims but also for key words on websites to identify diseases as search terms to find its products.

No Change To US FDA’s Risk-Based Homeopathic Enforcement From Its OTC Monograph Overhaul

Final guidance presents same descriptions of six "categories of homeopathic drug products ... potentially posing higher risks to public health” agency stated in 2019 revised draft. Agency adds reference to monograph reform in explanation of how homeopathics aren't GRASE.  

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS153121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel